Stellus Capital Management, LLC (“Stellus”) announced today that its affiliates provided senior debt financing and an equity co-investment to support Graham Partners’ (“Graham”) acquisition of Rhythmlink International, LLC (“Rhythmlink” or the “Company”).

Headquartered in Columbia, South Carolina, Rhythmlink designs, manufactures and distributes custom single-use electrodes used to identify, elicit and record neurophysiological signals and monitor brain health. The Company supplies clinicians, external service providers and OEMs with a broad portfolio (500+ SKUs) and its products are custom tailored to address workflow challenges, evolving hospital protocols and unique patient needs.

“We are excited to partner with Graham on another transaction and look forward to working with them and the entire Rhythmlink management team,” said Doug Bollermann, Managing Director at Stellus. “We believe Rhythmlink’s leading market position, unique value proposition and favorable underlying demand drivers position the Company for continued long-term success. Graham’s breadth of investing experience in the healthcare and technology sectors will serve as a strong foundation to support the Company’s continued growth.”

About Stellus Capital Management

Stellus was founded in 2012 and formed in conjunction with the spin-out of the Direct Capital Unit of the D. E. Shaw group. Stellus’ senior team helped create the Direct Capital Unit in 2004 and has been investing together in the middle market for 18 years. Since 2004, the Stellus team has deployed over $8 billion into more than 350 middle market companies, developing a broad and deep expertise in this segment of the private investing market. Stellus currently has approximately $2.6 billion in assets under management, with offices in Houston, TX, the Washington, D.C. area, and Charlotte, NC. Learn more at stelluscapital.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005309/en/